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Abstract
Background: Diaphragmatic assessment by ultrasound (US) is a non-invasive and useful method in the clinical
management of patients with Amyotrophic Lateral Sclerosis (ALS). The aim of our observational study was to
evaluate the impact of serial assessment of the diaphragmatic function by US on long-term outcomes in a series of
patients suffering from ALS and to correlate US indices of diaphragmatic function and respiratory function tests with
these outcomes.
Methods: A cohort of 39 consecutive patients has been followed up to 24months. Both lung volume (forced vital
capacity, FVC) and diaphragmatic pressure generating capacity (by sniff inspiratory nasal pressure (SNIP) and by both
US thickening fraction, ΔTdi, and the ratio of the thickening fraction between tidal volume and maximal lung capacity,
ΔTmax) were recorded at baseline and every 3 months. Parameters were then correlated with outcomes (nocturnal
hypoventilation, daily hypercapnia, start of ventilatory support (NIV), and death at 1 year) over time.
Results: The occurrence of ΔTmax > 0.75 increased the risk to start NIV (HR = 5.6, p = 0.001) and to die (HR = 3.7, p =
0.0001) compared with patients maintaining lower values. Moreover, compared with the occurrence of FVC < 50% of
predicted, ΔTmax > 0.75 appeared slightly better correlated with NIV commencement within 6 months.
Conclusions: Serial diaphragmatic assessment by ultrasound is a useful and accurate method to predict the initiation
of NIV earlier in patients with ALS.
Keywords: Amyotrophic lateral sclerosis, Respiratory failure, Mechanical ventilation, Diaphragm dysfunction, Diaphragm
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Background
Amyotrophic Lateral Sclerosis (ALS) is a progressive
neurodegenerative disease involving the motor neurons
of the cortex, brainstem and spinal cord. The leading
cause of death in these patients is the onset of hypercap-
nic respiratory failure due to progressive respiratory
muscle involvement, including diaphragmatic dysfunc-
tion [1].
The early assessment of diaphragmatic function might
therefore be essential to prompt non-invasive mechan-
ical ventilation (NIV) with the aim of increasing survival
and improving quality of life in these patients [2]. Over-
all, the early appliance of NIV reduces the progressive
loss in forced vital capacity (FVC) and balances the
effects of nocturnal hypoventilation [3, 4]. Currently,
NIV is recommended when respiratory symptoms begin
and lung function tests, namely FVC, decline to suggest
failure of the respiratory system [5].
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The routinely used evaluations of both lung volumes
(namely FVC by spirometry) and diaphragmatic pressure
generating capacity (by sniff nasal inspiratory pressure test
(SNIP)) require the patient’s full collaboration and coord-
ination, thus very often they are not very informative [6, 7]
in those subjects with severe bulbar dysfunction or fronto-
temporal dementia. Other neurophysiological tests to
assess diaphragmatic function (i.e. phrenic nerve stimula-
tion) can be helpful though uncomfortable and/or difficult
to perform routinely [8–10].
Recently, diaphragmatic assessment by ultrasound (US)
has been used to distinguish between normal status and
dysfunction [11–13] in different clinical settings [14, 15].
This technique requires little patient collaboration unlike
the other volitional tests mentioned above [11, 16].
Pinto et al. demonstrated that diaphragm thickness by
US correlated with compound motor action potential of
the phrenic nerve [17]. Our group showed that US-de-
rived indices of diaphragmatic function (thickening frac-
tion, ΔTdi, and the ratio of the thickening fraction
between tidal volume and maximal lung capacity,
ΔTmax) correlated with respiratory function tests in pa-
tients with ALS [12]. In particular, we have found that
ΔTmax is better correlated with diaphragmatic dysfunc-
tion than FVC, whose value when lower than 50% of
predicted is still recognized as the threshold limit to
prompt NIV.
The aim of this study was therefore to evaluate the
impact of serial assessment of ΔTmax on long-term out-
comes in a series of patients suffering from ALS and to
correlate US measurements of diaphragmatic function
and respiratory function tests with these outcomes.
Methods
Study population
This prospective observational cohort study was car-
ried out at the Respiratory Diseases Unit of the Uni-
versity Hospital of Modena (Italy) over a 36-month
period, from January 2013 to January 2016. Patients
were recruited from among those referred to the Cen-
ter of ALS-Neurology Unit of the University Hospital
of Modena, with the possible, probable, probable la-
boratory-supported or definite diagnosis of ALS (spor-
adic or familiar) according to the revised El Escorial
criteria [18].
Inclusion criteria for the present study were as follows:
– Age > 18 years.
– Consensus on diagnosis reached < 24 months before
enrollment.
– Ability to perform volitional pulmonary function
tests (spirometry and sniff test).
– ΔTmax > 0.75 at first visit.
Patients already developing respiratory failure, on NIV
regimen or tracheostomy, and those who were pregnant
or breastfeeding were excluded.
The Ethics Committee “Comitato Etico dell’Area Vasta
Emilia Nord” (Italy) approved the study protocol (regis-
tered protocol number 839/C.E.) and written informed
consent to participate was obtained from all patients.
Clinical and functional assessment
Individual clinical (including BMI) and functional data
were collected at baseline and every 2–3 months over 2
years.
At baseline, the following information was recorded:
family history, gender, age of onset, type of ALS (spinal or
bulbar), presence of dementia or extrapyramidal signs,
current therapy. In addition, nocturnal standard 4-channel
cardiorespiratory monitoring (Embletta PDS™, Flaga hf
Medical Devices, Reykjavik, Iceland) was performed at this
time to detect hypoventilation.
At each visit during follow-up, patients underwent
complete respiratory function (namely pulmonary and
diaphragmatic) assessment including spirometry, arterial
blood gas analysis, sniff test, and US of the diaphragm
by expert technicians blinded to the study purpose.
Pulmonary function tests
Spirometry (MasterScreen™ Jaeger, Vyaire Medical Inc.,
Mettawa, IL, USA) was performed with the patient in
the sitting position, and measurements were carried out
complying with American Thoracic Society guidelines
[19]. The best value out of 3 forced expirations obtained
after a maximal inspiration was recorded to determine
the FVC.
Before spirometry, a blood sample was taken from the
radial artery for analysis of blood gases, while the patient
was breathing ambient air at rest; arterial oxygen tension
(pO2), carbon dioxide tension (pCO2), and pH were
obtained by an automatic analyzer (ABL90FLEX™, Radi-
ometer Medical ApS, Copenhagen, Denmark). The day
before spirometry was performed patients underwent
nocturnal oxymetry registration in order to detect the
onset of nocturnal hypoventilation.
Diaphragmatic function tests
The Sniff test was conducted by inserting a plug in a nostril
and connecting it to a pressure transducer (MicroRPM™,
CareFusion, Florence, Italy) while the patient performed a
maximal inspiratory maneuver through the contralateral
nostril. The best SNIP value was recorded among 20
maneuvers starting from functional residual capacity (FRC)
and performed every 30 s [16]. FVC > 80% of the predicted
value and SNIP test below 70 cmH2O in men and 60
cmH2O in women were considered to be normal reference
values [16, 19].
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US examination of the diaphragm was performed
while in the sitting position by a system (GE Vivid 7,
KPI Healthcare, Yorba Linda, CA, USA) connected to a
7–12MHz linear probe set to B mode. The probe was
positioned to derive the best possible view of the dia-
phragm searching the point of apposition between the
mid-axillary and the posterior-axillary lines. The dia-
phragm was identified as a three-layered structure
consisting of one relatively non-echogenic muscle layer
covered by two echogenic lines determined by periton-
eal serosa and diaphragmatic pleura. Diaphragm thick-
ness at the end of exhalation was measured in the area
of apposition. During US assessment of diaphragm
function a spirometer was used to ensure the correl-
ation with the phase of the respiratory cycle. Since the
increase in diaphragm thickness during inhalation was
used as an indirect measure of muscle contraction, the
changes in thickness during tidal volume and after
maximal inspiration to total lung capacity (TLC) were
also taken [1] (Additional file 1: Figure S1). Measure-
ments were performed three times on both sides of the
diaphragm. Images were stored in electronic format
and the best out of 3 measurements was recorded for
analysis. US measurements were performed just before
the patients had undergone respiratory function tests.
Change in diaphragm thickness (Tdi) during inspir-
ation starting from FRC to Vt (so called thickening frac-
tion ΔTdi = [(end-inspiratory Tdi – end-expiratory Tdi)
/ end-expiratory Tdi] × 100) and the ratio between Tdi
at the end of Vt and Tdi after maximal inspiration up to
TLC (ΔTmax = end-inspiratory Vt Tdi / end-inspiratory
TLC Tdi) were determined. According to previous data,
ΔTdi < 20% and ΔTmax > 0.75 were considered thresh-
olds for diaphragmatic dysfunction [12].
Outcome measures
The association between occurrence of pathological
ΔTmax and NIV initiation and mortality were the pri-
mary outcomes considered for analysis. The decision to
start NIV was taken by a multidisciplinary team un-
aware of the results obtained by diaphragmatic US
assessment and rigorously following the specific criteria
set by the American Academy of Neurology with par-
ticular regard to respiratory function tests [20]. During
the follow-up, the following were also registered: the
onset of nocturnal hypoventilation defined as a de-
crease in hemoglobin saturation below 88% for more
than 5 min starting from a hemoglobin saturation level
during waking state above 90%, and daily hypercapnia
defined as arterial blood pCO2 above 45 mmHg [21].
Among patients undergoing NIV treatment, the associ-
ation between time course of ΔTmax value and mortal-
ity was also investigated.
Statistical analysis
The statistical package GraphPad Prism 7.0 (GraphPad
Software, Inc., La Jolla, CA, USA) was used for statistical
analysis. A p value lower than 0.05 was considered to be
statistically significant.
Descriptive statistics were used for demographic, clinical
and instrumental variables. Kaplan–Meier curve analysis
was used to investigate the impact of ΔTmax > 0.75 or <
0.75 on NIV start and mortality compared to FVC > 50%
or < 50%. Linear regression analysis of covariance was
applied to ΔTmax time course in the whole sub-group of
patients who started NIV and according to their survival
within 1 year (survivors and non-survivors). Contingency
table analysis for relative risks was used to compare the
traditional FVC and SNIP metrics with the proposed new
ultrasound guided indices (ΔTmax and ΔTdi) in predicting
the onset of recorded clinical outcome measures (hypercap-
nia, nocturnal hypoventilation, NIV start, and death).
Results
In total, 66 consecutive outpatients with ALS were re-
ferred to our Unit. Out of these, 39 subjects fulfilled
entry criteria and were enrolled in the study; 27 already
presented an abnormal ΔTmax (> 0.75) and were there-
fore excluded (see Fig. 1).
The general characteristics and clinical features of the
population at study baseline are presented in Table 1. Of
note, 12 patients (31%) presented a bulbar onset of their
disease. At that time, US indices ΔTmax and ΔTdi and
respiratory function variables FVC and SNIP were not
significantly different between patients with bulbar or
spinal involvement.
Ten out of the 39 patients (26%) had normal ΔTmax
values during the follow-up (Fig. 1). Among these, 4 died
due to causes unrelated to ALS-induced ventilatory failure
(2 ischemic heart disease, and 2 sepsis). Out of the 29
patients who shifted to an abnormal ΔTmax, 25 received
NIV, while 3 died before receiving NIV, and 1 refused
treatment. On average, an abnormal ΔTmax value pre-
ceded the decision to start NIV by 2.8 months (IQR 0.4–
5.4 months) compared with criteria based on assessment
with respiratory function tests. The time from NIV start
to death was 8.9 months (IQR 3.1–15.8months).
Figure 2 presents the Kaplan–Meier curves of both
NIV-free and survival rates in groups with normal (< 0.75)
or abnormal (> 0.75) ΔTmax as recorded over time com-
pared to FVC values below or above 50%; the risk to start
NIV (HR = 5.6, p = 0.001) and to die (HR = 3.7, p = 0.0001)
was several-fold increased in patients with ΔTmax > 0.75
and/or with FVC below 50% compared with others. In
addition, change over time of average ΔTmax in the 25
patients who started NIV and according to survival is
shown Fig. 3; the trend of ΔTmax clearly and significantly
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differed (p = 0.027) between patients who survived or died
following NIV.
Contingency table analysis for relative risks of respira-
tory function (FVC, SNIP) and US (ΔTmax, ΔTdi) vari-
ables in predicting the onset of the outcomes considered
is summarized in Table 2. Notably, the occurrence of
FVC < 50% of predicted and the presence of ΔTmax >
0.75 in the follow-up period, share similar relative risks
for starting NIV within 6 months and death within 12
months.
Discussion
With this prospective observational study, we have demon-
strated that serial diaphragmatic assessment by ultrasound
may be useful to predict initiation of NIV and death in pa-
tients with ALS. The occurrence of an abnormal ΔTmax
value over time preceded the decision to start NIV.
From technical point of view, the site of US exploration
of the diaphragm changes among studies. For example
Pinto et al. [8] used the space between the mid axillary and
antero-axillary lines while Carriè [22] et al. explored the
area between the mid clavicular and anterior axillary line.
In our study in order to perform highly accurate US evalu-
ation of the diaphragm, the probe was positioned to ex-
plore the point of apposition between the mid-axillary and
Fig. 1 Flow diagram for the patients in this study
Table 1 Characteristics of the study population at baseline.
Data are presented as number/percentage for dichotomous




Male (n/%) 27 (69)
Age (years) 65.9 (57–74)
BMI 25.3 (21.2–27.8)
Bulbar onset (n/%) 12 (31)
Age at diagnosis (years) 65 (56–71)
Time to death from ALS
diagnosis (months)
41.1 (12.9–68.1)
FVC (% predicted) 82.4 (60.5–103)
Arterial paCO2 (mmHg) 40.9 (37.6–43.4)
SNIP (cmH2O) 50 (39–66.5)
US ΔTmax 0.60 (0.52–0.69)
US ΔTdi Vt (%) 51 (28.4–70.4)
Follow-up duration (months) 14 (6–24)
Legend: FVC Forced Vital Capacity, paCO2 partial arterial carbon dioxide, SNIP
Sniff Inspiratory Nasal Pressure, US Ultrasound, ΔTmax ratio between diaphragm
thickness at the end of tidal volume and after maximal inspiration, ΔTdi Vt
change in diaphragm thickness during spontaneous breathing at tidal volume
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the posterior-axillary lines. We decided to choose the point
of apposition as to detect the thicker part of the muscle in
order to minimize possible measurements errors.
A ΔTmax value > 0.75 has previously been demonstrated
by our group as the threshold limit of normal diaphrag-
matic function in patients with ALS [12]. In particular, we
were able to show that ΔTmax > 0.75 presented a 75%
sensitivity and 85% specificity in identifying subjects with
FVC values lower than 50% of the predicted value. To date,
FVC is still considered the most valid measure to decide
when to apply NIV and to manage respiratory failure in
these patients [20]. Quite interestingly, we provide new
information suggesting that deterioration of ΔTmax, al-
though at a risk similar to the behavior of FVC, precedes
Fig. 2 Kaplan–Meyer curves for percentage of patients NIV-free (panel a) and percentage survival (panel b) during follow-up according to their normal
(ΔTmax < 0.75) or abnormal (ΔTmax > 0.75) threshold levels of diaphragmatic dysfunction as assessed by the ultrasound monitoring technique
Fig. 3 Average time course of ΔTmax as recorded by the ultrasound technique in Survivors (panel a) and Non-survivors (panel b) undergoing NIV.
Continuous line indicates the period under unassisted breathing, dotted portion shows the period following NIV commencement
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the occurrence of a threshold limit to prompt NIV by
around 3months.
In addition, the occurrence of abnormal ΔTmax over
time correlates with mortality similar to the occurrence
of abnormal FVC, still the best respiratory prognostic
indicator of survival and disease progression in ALS
[23]. Moreover, since we were able to demonstrate that
the occurrence of an abnormal ΔTmax in a patient is a
risk factor for the development of daily hypercapnia and
nocturnal hypoventilation, these findings taken together
strengthen the potential role of the noninvasive US
assessment of the diaphragm in this clinical setting.
In our study, we have shown that the occurrence of an
abnormal thickening fraction of the diaphragm (ΔTdi <
20%) [15] is a significant risk factor for the onset of daily
hypercapnia and nocturnal hypoventilation and the need
for non-invasive mechanical ventilation within 6months
(see Table 2). However, we did not find a significant rela-
tionship between ΔTdi < 20% and death in the following
12months. Though this finding might seem contradictory
if we consider ΔTdi to be a late index of diaphragmatic
dysfunction (see discussion which follows), it could be ex-
plained by the small number of patients developing ΔTdi
< 20% (n = 9). Therefore, though ΔTmax and ΔTdi, as a
surrogate measure of diaphragmatic pressure generating
capacity, might seem similar in describing diaphragmatic
function, they could provide different information on
muscle status.
When the change in diaphragm thickness (ΔTdi) in the
area of apposition is lower than 20%, diaphragmatic dys-
function should be considered very severe and close to par-
alysis [13]. As such, this finding is certainly useful; however,
it only allows identification of the late phase of dysfunction,
but not an early stage of muscle fatigue and/or weakness.
Muscle fatigue can be defined as a condition characterized
by a reduction in muscle capacity to generate force when
subjected to a given load. This condition is reversible
following rest for a certain period of time, and it is different
from the concept of muscle weakness where the ability to
restore strength after rest is compromised [24, 25].
In neuromuscular diseases, the elastic load of the respira-
tory system increases due to different factors causing the
reduction in lung distensibility: 1) loss of gas-containing al-
veoli (patchy atelectasis), 2) generalized increase in surface
tension of the alveolar lining layer caused by breathing at
low volume, 3) alteration in lung tissue elasticity [26].
Therefore in patients suffering from ALS, the increase in
elastic load to which the respiratory muscles are subjected
(with the consequent increase in transdiaphragmatic pres-
sure [Pdi]), and the reduction in inspiratory muscle force
(reduction in maximal Pdi), lead to a Pdi/Pdimax ratio
which predisposes to the development of diaphragmatic
fatigue.
With this scenario, the non-invasively obtained ΔTmax,
as a surrogate measure of Pdi/Pdimax ratio, could be used
to provide specific information about the fatigue status of
the diaphragm in patients with ALS. Despite this assump-
tion presenting obvious limitations, it is possible to deduce
that, when the thickness of the diaphragm at the end of
the tidal breath approaches the thickness at TLC, we are
probably close to the area of “fatigue/weakness” of the
muscle [25].
In our study the average starting point for ΔT max
was worse for the non-survivor group but the two values
did not differ significantly (0.44 VS .51, p = 0.32). We
thus believe that the two groups may be considered
homogeneous at the beginning of assessment. Patients
treated with long-term ventilator support and with bet-
ter prognosis showed a stabilization of ΔTmax over time
following the beginning of NIV (see Fig. 3). This could
mean that, in these patients, diaphragmatic function was
in the “fatigue area” with muscle rest provided by NIV
able to improve performance, whereas in those who died
under NIV, the progressive deterioration of ΔTmax is
likely to suggest that their diaphragm was in a “weakness
zone” which received no benefit from rest (NIV).
If confirmed on larger populations and/or in compari-
son with other physiological indices, this information on
the status of the diaphragm as obtained non-invasively
by the US technique could be extremely important in
identifying the subset of patients with ALS at greater
benefit from early ventilatory support.
Notwithstanding, the present findings only provide
preliminary information and at best open a new avenue.
Table 2 Contingency table analysis of risks for clinical outcomes among the functional indices as recorded in the study patients.
Data are presented as relative risk [95% CI] (p value)
Variable Outcome
Hypercapnia Nocturnal hypoventilation NIV start within 6 months Death within 12 months
ΔTmax > 0.75 3.3 [1.14–6.72] (0.01) 3.11 [1.03–8.64] (0.03) 2.1 [1.09–4.5] (0.01) 2.5 [1.15–5.4] (0.02)
ΔTdi Vt < 20% 1.7 [1.02–3.4] (0.04) 2 [1.03–4-44] (0.01) 2.0 [1.08–5.3] (0.03) 2.6 [0.87–5.4] (0.2)
SNIP < 40 cmH2O 4.2 [1.9–6.9] (< 0.001) 2.9 [1.05–4.9] (0.005) 1.7 [1.3–5.5] (0.001) 1.6 [1.16–6.5] (0.04)
FVC < 50% 3.2 [1.2–7] (0.006) 3 [1.1–7.5] (0.01) 1.8 [1.2–3.4] (0.01) 2.2 [1.04–6.4] (0.03)
Legend: ΔTmax ratio between diaphragm thickness at the end of tidal volume and after maximal inspiration, ΔTdi Vt change in diaphragm thickness during
spontaneous breathing at tidal volume, SNIP Sniff Inspiratory Nasal Pressure, FVC Forced Vital Capacity
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Indeed, the lack of comparison between the US assess-
ment of diaphragmatic function and other methods used
to assess its contractility [16] still remains a major limita-
tion. Moreover our study lacks from data on intra- and in-
ter-rater variability for the US measurements performed.
Conclusions
This study suggests that serial diaphragmatic assessment
by ultrasound may help identifying patients who require
NIV earlier. Further studies to demonstrate correlation
with other clinical markers and clinical outcomes are
needed.
Additional file
Additional file 1: Figure S1. Correlation between lung volume and
thickness of the diaphragm assessed by ultrasound technique. The
arrows indicate the thickness of the diaphragm at Total Lung Capacity
(TLC), Tidal Volume (Vt), Functional Residual Capacity (FRC). (PNG 508 kb)
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